Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: Parameters associated with prophylactic and therapeutic vaccine efficacy

Vaccine

Volumn 20, Issue 3-4, 2001, Pages 413-420

  Koesling, Jan ^a   Lucas, Bernadette ^a   Develioglou, Leyla ^a   Aebischer, Toni ^a   Meyer, Thomas F ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

Gastric mucosa; Humoral immune response; Spleen colonization

Indexed keywords

ANTIBODY; HELICOBACTER PYLORI VACCINE; LIVE VACCINE; UREASE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM MUTANT; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; FEMALE; GENETIC ENGINEERING; GENETIC VARIABILITY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HOST; IMMUNE RESPONSE; IMMUNITY; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RECOMBINANT PLASMID; SALMONELLA TYPHIMURIUM; STRAIN DIFFERENCE; TREATMENT OUTCOME; VACCINATION;

ANIMALS; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HELICOBACTER PYLORI; MICE; MICE, INBRED STRAINS; RECOMBINANT PROTEINS; SALMONELLA TYPHIMURIUM; SPECIES SPECIFICITY; UREASE; VACCINATION; VACCINES, SYNTHETIC;

EID: 0035851318     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00355-3     Document Type: Article

References (51)

1. Helicobacter pylori
2. Host determinants of Helicobacter pylori infection and its clinical outcome
3. Helicobacter pylori virulence and genetic geography
4. Immunization against gastric Helicobacter infection in a mouse/Helicobacter felis model
5. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection
6. Development of a mouse model of Helicobacter pylori infection that mimics human disease
7. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II restricted responses
8. Catalase, a novel antigen for Helicobacter pylori vaccination
9. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease
10. Therapeutic immunization against Helicobacter infection
11. c expressing urease A and B subunits
12. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B
13. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions
14. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies
15. T cell subsets: Recruiting the right kind of help
16. Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains
17. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection
18. Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium
19. Control by H-2 genes of the Th1 response induced against a foreign antigen expressed by attenuated Salmonella typhimurium
20. Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nramp1 influences T helper subset responses and protection against leishmanial challenge
21. Role of H-2 and non-H-2 genes in control of bacterial clearance from the spleen in Salmonella typhimurium-infected mice
22. Th1 response in Salmonella typhimurium-infected mice with a high or low rate of bacterial clearance
23. The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens
24. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response
25. Induction of specific cell-mediated immunity in mice by oral immunization with Salmonella expressing Onchocerca volvulus glutathione S-transferase
26. Immunization with live versus killed Salmonella typhimurium leads to the generation of an IFN-γ-dominant versus an IL-4-dominant immune response
27. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
28. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine
29. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria
30. Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori
31. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection
32. Role of γ-interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model
33. Systemic immunization with urease protects mice against Helicobacter pylori infection
34. Murine CD4+ T cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load
35. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: Expression of interleukin-10 in interferon-γ and in interleukin-4 expressing cells
36. Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-γ in CD4+ T cells
37. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella
38. Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses
39. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection
40. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen
41. Protective immunity induced in mice by detoxified Salmonella lipopolysaccharide
42. Virulence of antibiotic-resistant Salmonella typhimurium
43. Modulation of host immune responses stimulated by Salmonella vaccine carrier strains by using different promoters to drive the expression of the recombinant antigen
44. Effect of different plasmids on colonization of mouse tissues by the aromatic amino acid-dependent Salmonella typhimurium SL3261
45. Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters
46. Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers
47. Use of the stationary phase inducible promoters, spv and dps, to drive heterologous antigen expression in Salmonella vaccine strains
48. Levels of expression and immunogenicity of attenuated Salmonella enterica serovar typhimurium strains expressing Escherichia coli mutant heat labile enterotoxin
49. Protection against oral challenge 3 months after i.v. immunization of BALB/c mice with live Salmonella typhimurium aroA and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen
50. Correlates of protection induced by live Salmonella typhimurium aroA vaccines in the murine typhoid model
51. Clonal expansion of antigen-specific CD4+ T cells following infection with Salmonella typhimurium is similar in susceptible (Itys) and resistant (Ityr) BALB/c mice